Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
Open Access
- 8 March 2022
- journal article
- letter
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 135 (21) , 2623-2624
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 4 references indexed in Scilit:
- Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 studyAnnals of the Rheumatic Diseases, 2017
- IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseasesNature Medicine, 2015
- Inflammatory Back PainRheumatic Disease Clinics of North America, 2012
- Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trialThe Lancet, 2002